Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
3594 studies found for:    Open Studies | "Carcinoma"
Show Display Options
Rank Status Study
1 Recruiting MLN0128 in Recurrent/Metastatic Merkel Cell Carcinoma
Condition: Merkel Cell Carcinoma
Intervention: Drug: MLN0128
2 Recruiting Laparoscopic Versus Open Liver Resection in the Treatment of Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Procedure: Laparoscopic liver resection;   Procedure: Open liver resection
3 Recruiting 18F-FluoroethylCholine Positron Emission Tomography: a Promising Diagnostic Tool for Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Intervention: Device: 18F-FluoroethylCholine PET
4 Recruiting Evaluation of Treatment Response With Integrated MRI/PET in Patients With Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Intervention: Device: The imaging biomarkers determined by MR-PET
5 Not yet recruiting Study of TAK-228 In Patients With Previously Treated Metastatic Renal Cell Carcinoma
Condition: Renal Cell Carcinoma
Intervention: Drug: TAK-228
6 Recruiting Pembrolizumab (Keytruda) in Advanced Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Drug: Pembrolizumab;   Procedure: Peripheral Blood Sample (optional);   Genetic: Tumor Tissue Collection (optional)
7 Recruiting Study of Apatinib in Advanced Hepatocellular Carcinoma(HCC)
Condition: Hepatocellular Carcinoma
Intervention: Drug: Apatinib
8 Recruiting Mechanism of Sorafenib Resistance in Patients With Advanced Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Intervention: Drug: Sorafenib
9 Recruiting Liver Perfusion MRI With Quantification of Tumoral Perfusion for Early Assessment of the Response of Antiangiogenics Treatments in Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Intervention: Device: liver Perfusion MRI
10 Not yet recruiting A Study to Evaluate Autologous CIK Cells in Patients With Hepatocellular Carcinoma After TACE, PEIT or RFA
Condition: Hepatocellular Carcinoma
Intervention: Biological: CIK Cell
11 Recruiting Ipsilateral Liver Lobe Devascularization of the Large Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Intervention: Procedure: ILAD
12 Recruiting Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma
Condition: Adenoid Cystic Carcinoma
Interventions: Radiation: Radiation;   Drug: Pembrolizumab
13 Not yet recruiting Study of the Combination of TACE With Apatinib in Patients With Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Procedure: TACE and Apatinib;   Procedure: TACE
14 Recruiting SBRT for Hepatocellular Carcinoma Patients With Partial Response to TACE
Condition: Carcinoma, Hepatocellular
Intervention: Radiation: SBRT
15 Recruiting A Multi-center, Open-label Study of Oral ENMD-2076 for the Treatment of Patients With Advanced Fibrolamellar Carcinoma
Conditions: Advanced Adult Hepatocellular Carcinoma;   Advanced Fibrolamellar Carcinoma
Intervention: Drug: ENMD-2076
16 Recruiting Phase 2, Randomized, Double-Blind, Placebo-Controlled of the Efficacy and Safety of CF102 in Hepatocellular Carcinoma (HCC)
Condition: Hepatocellular Carcinoma
Interventions: Drug: CF102;   Drug: Placebo
17 Not yet recruiting A Study of DC-CIK to Treat Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma (HCC)
Intervention: Biological: Dendritic and Cytokine-induced Killer Cells
18 Not yet recruiting Study of Milciclib in Patients With Unresectable/Metastatic Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Intervention: Drug: Milciclib maleate
19 Not yet recruiting Glypican 3-specific Chimeric Antigen Receptor Expressing T Cells for Hepatocellular Carcinoma (GLYCAR)
Condition: Hepatocellular Carcinoma
Interventions: Genetic: GLYCAR T cells;   Drug: Cytoxan;   Drug: Fludarabine
20 Not yet recruiting Chidamide for Advanced Cephalic and Cervical Adenocystic Carcinoma: Evaluation of Efficiency and Safety
Condition: Adenocystic Carcinoma
Intervention: Drug: Chidamide

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.